7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one, 95.0%, 2.5g

(2-Chloro-4-isopropoxyphenyl)boronic acid, 95.0%, 5g

2-(2-METHYL-3-NITROPHENYL)-N,N-DIPROPYLACETAMIDE, 97.0%, 250mg

2-Chloro-4-(thiazol-5-yl)phenyl trifluoromethanesulfonate, 95%, 50mg

4-(Pyrimidin-5-ylethynyl)benzaldehyde, 95.0%, 250mg

GC capillary column ROTI®Cap-5 MS Ultra, 30 m, 0.32 mm, 0.50 µm, 1 Piece(s)

Reaction vial rack SEKUROKA® for anti-radiation box Midi, Gesch. for, 0.5 ml reaction vials, 1 piece

2-Mercaptobenzimidazole>98.0%(HPLC)(T)25g

4-Amino-N-(2-diethylaminoethyl)benzamide, 95.0%, 1g

PRANOPROFEN, 95%, 10g

1,3-Di-n-octyltetramethyldisiloxane, 95%, 10g

Polydimethylsiloxane, trimethylsiloxy terminated 500cSt, 3kg

((Benzyloxy)carbonyl)-L-phenylalanyl-L-methionine, 98%, 5g